Evidence map›Paper›PMID 10200320›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1999

Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2.

T V Petrova, K T Akama, L J Van Eldik

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 314 citations in OpenAlex.

  1. Article
  2. Review
  3. MicroRNAs in shaping the resolution phase of inflammation.Seminars in cell & developmental biology · 2022
    Review
  4. Review
  5. Article
  6. Cyclooxygenase-2 Induced the β-Amyloid Protein Deposition and Neuronal Apoptosis Via Upregulating the Synthesis of Prostaglandin ENeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2019
    Article
  7. Anti-inflammatory activity of rhein isolated from the flowers ofSaudi journal of biological sciences · 2019
    Article
  8. Article
  9. 15d-PGJ2 is a new hope for controlling tumor growth.American journal of translational research · 2018
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Fetal alcohol spectrum disorders and neuroimmune changes.International review of neurobiology · 2014
    Review
  17. Article
  18. Article
  19. Article
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

T V PetrovaDepartment of Cell and Molecular Biology, Northwestern University Medical School, Chicago, IL 60611, USA.
K T Akama
L J Van Eldik
Northwestern University · US

Funding

CELLULAR &MOLECULAR BASIS OF DISEASE TRAINING PROGRAMT32GM008061 · NIGMS · NORTHWESTERN UNIVERSITY · PI CARTHEW, RICHARD W. · 1985 to 2022
$17.1M
MOLECULAR MECHANISMS AND MODULATION OF GLIAL ACTIVATIONR37AG013939 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI VAN ELDIK, LINDA J · 2000 to 2009
$2.3M
SUPRAMOLECULAR A/BETA--GLIAL INTERACTIONS &CELL RESPONSR01AG013939 · NIA · NORTHWESTERN UNIVERSITY · PI VAN ELDIK, LINDA J · 1996 to 1999
–
NIA NIH HHS AG13939NIA NIH HHS R01 AG013939NIA NIH HHS R37 AG013939NIGMS NIH HHS GM08061NIGMS NIH HHS T32 GM008061
6 · The paper itself

Abstract

Mechanisms leading to down-regulation of activated microglia and astrocytes are poorly understood, in spite of the potentially detrimental role of activated glia in neurodegeneration. Prostaglandins, produced both by neurons and glia, may serve as mediators of glial and neuronal functions. We examined the influence of cyclopentenone prostaglandins and their precursors on activated glia. As models of glial activation, production of inducible nitric-oxide synthase (iNOS) was studied in lipopolysaccharide-stimulated rat microglia, a murine microglial cell line BV-2, and IL-1beta-stimulated rat astrocytes. Cyclopentenone prostaglandins were potent inhibitors of iNOS induction and were more effective than their precursors, prostaglandins E2 and D2. 15-Deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) was the most potent prostaglandin among those tested. In activated microglia, 15d-PGJ2 suppressed iNOS promoter activity, iNOS mRNA, and protein levels. The action of 15d-PGJ2 does not appear to involve its nuclear receptor peroxisome proliferator-activated receptor gamma (PPARgamma) because troglitazone, a specific ligand of PPARgamma, was unable to inhibit iNOS induction, and neither troglitazone nor 15d-PGJ2 could stimulate the activity of a PPAR-dependent promoter in the absence of cotransfected PPARgamma. 15d-PGJ2 did not block nuclear translocation or DNA-binding activity of the transcription factor NFkappaB, but it did inhibit the activity of an NFkappaB reporter construct, suggesting that the mechanism of suppression of microglial iNOS by 15d-PGJ2 may involve interference with NFkappaB transcriptional activity in the nucleus. Thus, our data suggest the existence of a novel pathway mediated by cyclopentenone prostaglandins, which may represent part of a feedback mechanism leading to the cessation of inflammatory glial responses in the brain.

Indexed as

AnimalsAstrocytesCell LineCell NucleusCloning, MolecularEpoprostenolGene Expression Regulation, EnzymologicInterleukin-1KineticsLipopolysaccharidesMicrogliaNitric Oxide SynthaseNitric Oxide Synthase Type IINitritesProstaglandin D2Protein Biosynthesis15-deoxy-delta(12,14)-prostaglandin J2EpoprostenolInterleukin-1LipopolysaccharidesNitric Oxide SynthaseNitric Oxide Synthase Type IINitritesNos2 protein, ratProstaglandin D2Recombinant Fusion ProteinsRNA, Messenger

Identifiers

PMID10200320
PMCPMC16390
OpenAlexW2015903618

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.